If you are unfortunate enough to find yourself suffering from the problem of cataract, you may be forgiven for thinking that the only way to improve your sight is to undergo lens replacement surgery. This, however, is no longer the case as there is a non-invasive alternative to cataract surgery in the form of a soothing eye drop called Can-C™, This breakthrough eye drop quickly improved the visual acuity of over 90% of the cataract patients tested in controlled clinical trials.



But what are Can-C Eye Drops and are they better than opting for cataract surgery? To answer specifically you must prepare to be taken back a bit to a few of the science lessons you had at school.

It is known by researchers that the young and healthy human eye contains high levels of a natural di-peptide antioxidant called L-carnosine. Scientists recently learned that the eyes of those who were developing cataracts, and other degenerative ocular diseases, were found to be extremely lacking in this particular, and essential, ocular antioxidant.

Dr. Mark Babizhayev MA PhD of Moscow, the senior research investigator for the clinical trials, used N-acetyl carnosine, a variation of L-carnosine that is suitable for ocular application, and refined it even further to a precise level of purity and specific intraocular-release delivering it safely into the aqueous humor (the fluid area inside the eye). This is where the bio-identical antioxidant once released, becomes most effective in its ability to reverse the lipid peroxidation that encourages the development of cataract.

So, science lesson over. The question is do they work? The answer is again; yes. Clinical trials showed that the consistent application of Can-C eye drops was very successful in not only halting any worsening of the disease but in actually improving the visual acuity of 90% the patients in the clinical trial. In simpler terms it is a reversal of the condition.

One of the clinical trials treated 96 patients aged 60 and above, all of which had senile cataract at various degrees of maturity. The duration of the disease in these patients ranged between 2 and 21 years. Firstly, the researchers stopped the patient's use of all other anti-cataract drugs. Then the patients instilled 1 or 2 drops into each eye 3 or 4 times a day, for a period of 3 to 6 months.

The level of eyesight improvement and the change of lens transparency were considered as an evaluation index. The results showed that there was a pronounced effect on primary senile cataract; the effective rate was 100%, which means that all of the patients showed improvement. For the more mature senile cataract the effective rate was 80%, which was equally remarkable considering that some of the patients had had cataracts for more than 20 years. It is also interesting to mention that there were no negative side effects and that in general there was an overall improvement of health throughout the eye.

When these statistics are taken into consideration compared to cataract surgery, it becomes quite clear that Can-C Eye Drops have the advantage. It is estimated by critics that around 26,000 individuals experience serious complications as a result of cataract surgery in the United States every year.

The considerable complication rate of cataract surgery is perhaps the main reason that much cataract research has been carried out over recent years. Additionally, members of particular research teams have noted that the artificial lens fitted in cataract surgery does not have the same overall optical qualities of our own natural lens.

Additionally the healing effects of Can-C eye drops appear to be very beneficial for many other eye conditions such as; glaucoma, contact lens disorders, corneal disorders, chronic eyestrain, blurred vision, dry eye syndrome and even floaters.

Of course, in some more severe cases Can-C will only slow the growth of the cataract and delay the likelihood of surgery, however for many this is a significant option.

Those wishing to apply the eye drops over a long period of time should always consult with their eye care physician

This article is free to republish provided the authors resource box remains intact.